Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-05-012683
Filing Date
2005-05-02
Accepted
2005-05-02 15:12:14
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2156803z10-ka.htm 10-K/A 125006
2 EXHIBIT 31.1 a2156803zex-31_1.htm EX-31.1 5705
3 EXHIBIT 31.2 a2156803zex-31_2.htm EX-31.2 5700
4 EXHIBIT 32.1 a2156803zex-32_1.htm EX-32.1 4247
5 G1016687.JPG g1016687.jpg GRAPHIC 34151
  Complete submission text file 0001047469-05-012683.txt   189405
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23776 | Film No.: 05790197
SIC: 2834 Pharmaceutical Preparations